Bluejay Diagnostics, Inc. Increase (Decrease) in Accounts Payable
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Accounts Payable of $459.83 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $453.80K.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $6.03K, a 98.39% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $53.09K.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $52.34K.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $69.13K.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$346.35K.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$235.76K, a 178.88% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable for fiscal 2022 was $298.88K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $453.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $459.83K 10-Q · filed 2026-08-12 | $512.93K derived: sum of 3 quarters · filed 2026-08-12 | $565.27K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $6.03K 10-Q · filed 2026-05-07 | $59.13K derived: sum of 2 quarters · filed 2026-05-07 | $111.47K derived: sum of 3 quarters · filed 2026-05-07 | -$299.24K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $53.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $105.44K derived: sum of 2 quarters · filed 2026-03-06 | -$305.27K derived: sum of 3 quarters · filed 2026-08-12 | $69.13K 10-K · filed 2026-03-06 | ||
| 2025-09-30 | $52.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$358.36K derived: sum of 2 quarters · filed 2026-08-12 | $16.04K 10-Q · filed 2025-11-07 | -$155.49K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | -$410.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$36.30K 10-Q · filed 2026-08-12 | -$207.83K derived: sum of 3 quarters · filed 2026-08-12 | -$381.24K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $374.40K 10-Q · filed 2026-05-07 | $202.87K derived: sum of 2 quarters · filed 2026-05-07 | $29.47K derived: sum of 3 quarters · filed 2026-05-07 | $247.70K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$171.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$344.93K derived: sum of 2 quarters · filed 2026-03-06 | -$126.70K derived: sum of 3 quarters · filed 2026-03-06 | -$346.35K 10-K · filed 2026-03-06 | ||
| 2024-09-30 | -$173.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $44.83K derived: sum of 2 quarters · filed 2025-11-07 | -$174.82K 10-Q · filed 2025-11-07 | -$387.48K 10-Q · filed 2024-11-07 | -$429.19K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $218.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.42K 10-Q · filed 2025-08-07 | -$214.07K 10-Q · filed 2024-08-14 | -$255.79K derived: sum of 3 quarters · filed 2025-08-07 | $192.41K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | -$219.65K 10-Q · filed 2025-05-13 | -$474.02K derived: sum of 2 quarters · filed 2025-05-13 | -$25.82K derived: sum of 3 quarters · filed 2025-05-13 | -$140.64K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$254.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $193.83K derived: sum of 2 quarters · filed 2025-03-31 | $79.01K derived: sum of 3 quarters · filed 2025-03-31 | -$235.76K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $448.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $333.38K derived: sum of 2 quarters · filed 2024-11-07 | $18.61K 10-Q · filed 2024-11-07 | $398.56K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$114.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$429.59K 10-Q · filed 2024-08-14 | -$49.64K derived: sum of 3 quarters · filed 2024-08-14 | -$31.04K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$314.77K 10-Q · filed 2024-05-15 | $65.17K derived: sum of 2 quarters · filed 2024-05-15 | $83.78K derived: sum of 3 quarters · filed 2024-05-15 | -$436.95K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $379.95K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $398.55K derived: sum of 2 quarters · filed 2024-03-28 | -$122.18K derived: sum of 3 quarters · filed 2024-03-28 | $298.88K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $18.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$502.13K derived: sum of 2 quarters · filed 2023-11-09 | -$81.07K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$520.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$99.67K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $421.06K 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$79.15K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |